Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

The functional groups and cofactors of Xist which contribute to X-chromosome inactivation

EF 2013-14

Résumé
The classic dogma of biology has been that proteins are the most important functional components of the cell; however, Ribonucleic Acids (RNAs) are now recognized as having the potential to exercise an equal or even greater role in mediating cellular functions and processes. Xist is a long, non-coding RNA gene which is critical for the survival of female mammals because it turns off one of the two X-chromosomes contained in each cell randomly early in development. As a result, only one of the X chromosomes in any given cell is active, effectively ensuring that the ideal genetic dosage is produced. Xist is the single most potent inhibitor of gene expression known. Furthermore, it has recently been shown that Xist is an effective treatment for Down’s syndrome, as it can be inserted into the extra, disease causing, chromosome 21 to neutralize it. In spite of its importance, it is not clear how Xist functions. Unravelling this mystery is the goal of my research. Previously the Brown lab identified two regions of Xist which seem to act redundantly, allowing Xist RNA to localize to the X-chromosome and mediate gene silencing. Interestingly, analysis of how Xist ""turns chromosomes off"" found two unique types of deactivating signals. One of the initial goals is to determine if the deletion of either of these domains modifies which silencing signal is recruited by Xist, indicating that these domains function through at partially independent pathways. I will test artificially designed DNA constructs containing either the full Xist gene or Xist containing partial deletions for their ability to recruit specific markers of genetic silencing, as deletions of functional regions should result in the loss of domain specific silencing markers. By narrowing down the deletions to the minimum size needed to disrupt specific aspects of chromosome silencing, I will be able to identify the function, location and structure of the critical domains in Xist. I will also analyze how these deletions influence the extent of a chromosome's silencing, by measuring the expression levels of genes located at various distances from Xist. This work will help to determine which domains are most important functionally for silencing gene expression. To remove the possibility of the cell’s own Xist genes interfering with this study, we will use male cell lines, which do not normally express Xist, and will use constructs located on autosomal (non-sex) chromosomes which are active in both sexes. In this manner, we will be able to clearly identify the Xist domains, the factors with which they interact, and their role in silencing gene expression on a large scale. Furthermore, while many proteins have been shown to be recruited by Xist, it is not yet clear how these different proteins interact during chromosome silencing. Since Xist seems to be the only clear common factor among all of these factors, identifying its functional groups will act as a gateway to understanding the interactions between gene regulatory pathways. While Xist itself is an incredibly powerful tool for regulating gene expression, it is also the most well known, long non-coding RNA (lncRNA), making it an ideal starting point from which to build a base for understanding this newly discovered population of genes. It is currently believed that lncRNA vastly outnumber protein coding genes, and may represent the most important component of the genome discovered to date. From a medical perspective, this research can be expected to provide new insights into the cause and treatments of X-linked disorders, including various types of cancer, neurodegenerative disorders, developmental disorders and even HIV/AIDS. Hence, this research is critical to medical advancement and all aspects of biological research.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
311908
Name
Dixon-McDougall Thomas A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The functional groups and cofactors of Xist which contribute to X-chromosome inactivation
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Deletions; Epigenetic; Fish; Functional Analysis; Gene Silencing; Heterochromatin; Immunoflouresence; Ncrna; X Inactivation; Xist
Abstract
The classic dogma of biology has been that proteins are the most important functional components of the cell; however, Ribonucleic Acids (RNAs) are now recognized as having the potential to exercise an equal or even greater role in mediating cellular functions and processes. Xist is a long, non-coding RNA gene which is critical for the survival of female mammals because it turns off one of the two X-chromosomes contained in each cell randomly early in development. As a result, only one of the X chromosomes in any given cell is active, effectively ensuring that the ideal genetic dosage is produced. Xist is the single most potent inhibitor of gene expression known. Furthermore, it has recently been shown that Xist is an effective treatment for Down’s syndrome, as it can be inserted into the extra, disease causing, chromosome 21 to neutralize it. In spite of its importance, it is not clear how Xist functions. Unravelling this mystery is the goal of my research. Previously the Brown lab identified two regions of Xist which seem to act redundantly, allowing Xist RNA to localize to the X-chromosome and mediate gene silencing. Interestingly, analysis of how Xist ""turns chromosomes off"" found two unique types of deactivating signals. One of the initial goals is to determine if the deletion of either of these domains modifies which silencing signal is recruited by Xist, indicating that these domains function through at partially independent pathways. I will test artificially designed DNA constructs containing either the full Xist gene or Xist containing partial deletions for their ability to recruit specific markers of genetic silencing, as deletions of functional regions should result in the loss of domain specific silencing markers. By narrowing down the deletions to the minimum size needed to disrupt specific aspects of chromosome silencing, I will be able to identify the function, location and structure of the critical domains in Xist. I will also analyze how these deletions influence the extent of a chromosome's silencing, by measuring the expression levels of genes located at various distances from Xist. This work will help to determine which domains are most important functionally for silencing gene expression. To remove the possibility of the cell’s own Xist genes interfering with this study, we will use male cell lines, which do not normally express Xist, and will use constructs located on autosomal (non-sex) chromosomes which are active in both sexes. In this manner, we will be able to clearly identify the Xist domains, the factors with which they interact, and their role in silencing gene expression on a large scale. Furthermore, while many proteins have been shown to be recruited by Xist, it is not yet clear how these different proteins interact during chromosome silencing. Since Xist seems to be the only clear common factor among all of these factors, identifying its functional groups will act as a gateway to understanding the interactions between gene regulatory pathways. While Xist itself is an incredibly powerful tool for regulating gene expression, it is also the most well known, long non-coding RNA (lncRNA), making it an ideal starting point from which to build a base for understanding this newly discovered population of genes. It is currently believed that lncRNA vastly outnumber protein coding genes, and may represent the most important component of the genome discovered to date. From a medical perspective, this research can be expected to provide new insights into the cause and treatments of X-linked disorders, including various types of cancer, neurodegenerative disorders, developmental disorders and even HIV/AIDS. Hence, this research is critical to medical advancement and all aspects of biological research.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dixon-McDougall, Thomas A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~